Targeting telomerase with an HLA class II-restricted TCR for cancer immunotherapy.
Dillard P, Köksal H, Maggadottir SMelkorka, Winge-Main A, Pollmann S, Menard M, Myhre MRenée, Mælandsmoe GM, Flørenes VAnn, Gaudernack G, et al. Targeting telomerase with an HLA class II-restricted TCR for cancer immunotherapy. Mol Ther. 2020.